Back to search

Article

In silico and in vitro analysis of recombinant arginine deiminase from Pseudomonas furukawaii as a potential anticancer enzyme

2022-01-21

Abstract excerpt

<title>Abstract</title> <p>Arginine deiminase (ADI), a promising anticancer enzyme from <italic>Mycoplasma hominis, </italic>is currently in phase III of clinical trials for the treatment of arginine auxotrophic tumors. However, it has been associated with several drawbacks in terms of low stability at human physiological conditions, high immunogenicity, hypersensitivity and systemic toxicity. In our previous wor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
90eef57c-b4fe-5637-b4a4-44f904bbdbfb
DOI
10.21203/rs.3.rs-1000203/v3
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
In silico and in vitro analysis of recombinant arginine deiminase from Pseudomonas furukawaii as a potential anticancer enzymeDOI 10.21203/rs.3.rs-1000203/v3
Select a neighboring publication to make it the new centre.